Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CSBR — Champions Oncology, Inc.

CIK 1214717 BOSTON, MA
Back to CSBR Full portfolio

Position in CSBR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$470,007
+$26,240 QoQ
Shares Held
76,300
-1.1% QoQ
Ownership
0.548%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 28 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSBR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. CSBR ranks #361 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CSBR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $470,007 76,300
2026-03-31 $443,767 77,177
2025-12-31 $523,908 75,819
2025-09-30 $482,170 74,409
2025-06-30 $554,113 75,185
2025-03-31 $652,162 75,134
2024-12-31 $569,998 66,511
2024-09-30 $316,861 65,064
2024-06-30 $326,154 63,086
2024-03-31 $304,358 62,114
2023-12-31 $344,781 61,349
2023-09-30 $380,977 61,349
2023-06-30 $375,884 58,916
2023-03-31 $202,817 50,452
2022-12-31 $227,529 50,450
2022-09-30 $357,285 47,638
2022-06-30 $381,104 47,638
2022-03-31 $387,296 47,638
2021-12-31 $398,253 47,638
2021-09-30 $486,383 47,638
2021-06-30 $441,556 42,953
2021-03-31 $1,048,843 92,818
2020-12-31 $994,589 92,177
2020-09-30 $849,002 91,784
2020-06-30 $879,557 92,004
2020-03-31 $323,639 43,735